[2025-12-17]9th Korea-US Joint Economic Forum Held

The Ministry of Foreign Affairs, in collaboration with KIEP, held the 9th Korea-US Joint Economic Forum in Seoul.
Vice Minister Kim Jin-ah evaluated the strengthened cooperation between Korea and the US and proposed focusing on shipbuilding, semiconductors, and energy sectors.
Approximately 150 attendees expressed high interest in cooperation in strategic industries between Korea and the US.

[2025-12-17]PPS Supports Multicultural Families for Winter

The Public Procurement Service visited Daejeon Foreigners Welfare Center and donated 200kg of kimchi to multicultural families.
Daejeon Foreigners Welfare Center has been supporting foreign workers, marriage immigrants, and international students since 2002.
The PPS ‘Beautiful People’ volunteer club has been consistently supporting the center since 2012.

[2025-12-17]2025 Second Zoonotic Disease Countermeasure Committee Held

The Animal and Plant Quarantine Agency and the Korea Disease Control and Prevention Agency held the second Zoonotic Disease Countermeasure Committee with related ministries and private experts.
The meeting focused on Severe Fever with Thrombocytopenia Syndrome (SFTS) and discussed management and response measures.
The agencies will strengthen inter-ministerial cooperation through the ‘One Health’ approach and enhance the zoonotic disease surveillance system.

[2025-12-17]KDCA Announces 2026 Work Plan

The Korea Disease Control and Prevention Agency (KDCA) announced its 2026 work plan, focusing on preparing for new infectious disease disasters, protecting the healthy daily lives of citizens, and proactively responding to future changes such as climate change.
In 2025, KDCA was recognized as having the world’s highest level of national health security capabilities by the WHO Joint External Evaluation and developed and commercialized the world’s first recombinant protein anthrax vaccine.
In 2026, KDCA plans to implement 10 key initiatives, including enhancing the infectious disease crisis response system, localizing infectious disease vaccines and treatments, and diversifying infectious disease diagnostic infrastructure.